|Articles|February 1, 2012
- Applied Clinical Trials-02-01-2012
- Volume 21
- Issue 2
Applied Clinical Trials Digital Edition - February 2012
TRIAL DESIGN : Enrollment is More Than a Numbers Game REGULATORY : Late Phase PK Collection Also in this issue : Protocol Design and Study Management, Effects of Europe?s Economic Turbulence, Ready for Big Data?, Outcomes Assessments
Advertisement
Articles in this issue
over 14 years ago
Unexpected Trend in Global Subject Enrollmentover 14 years ago
Increasing the Use of Technology in Feasibilityover 14 years ago
Pharmacovigilance Alliancesover 14 years ago
PPD Trains CRAs in Three Dimensionsover 14 years ago
Business and News Update February 2012over 14 years ago
Looking Beyond the Euro Turmoilover 14 years ago
Give the Patient a Clear Voiceover 14 years ago
Quality Approaches Key to Transforming Researchover 14 years ago
Strategic Partnershipover 14 years ago
Leveraging the TransitionAdvertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
FDA Pauses Real-Time Release of Drug Rejection Letters While Working to Formalize Policy
2
ACT Brief: Single Pivotal Trial Stakes, Configurable FSP Strategy, and G-CSF Biosimilar Portfolio Expansion
3
Tailoring Your FSP Approach: Why One Model Doesn’t Fit Every Trial
4
Bringing the Voice of Clinical Practice and Patients into Drug Development
5